20 October 2011, Lysaker, Norway: Company owned by primary insider and member of the board of directors' of Pronova BioPharma ASA, Hilde Furberg, has bought 20,000 shares in Pronova BioPharma ASA.

The shares were bought at an average share price of NOK 5.29 and are held by J&J Future Invest AS, which is owned 50% by Ms Furberg. The total number of shares held by J&J Future Invest AS, after the purchase, is 60,000.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.